
View larger version (90K):
[in a new window]
|
Fig. 1. Pdgfra-/- cells contribute minimally to limb bud and
cranial ectomesenchyme. (A-G,I) Pdgfra-/- ES cells
injected into ROSA26+/- blastocysts; chimeras after staining for
ß-galactosidase activity. (A-E) E10.5 chimeras that contain a high
percentage of Pdgfra-/- cells phenocopy
Pdgfra-/- embryos (A, CH1; B,C, CH2; D,E, CH3; see
Table 1). (C,E) Transverse
sections through chimeras shown in B and D at the cranial and cardiac crest
level, respectively. (F) Transverse section through hindlimb bud of 50% mutant
cell derived chimera (CH8). Inset shows a section through forelimb bud with
predominantly Pdgfra-/- contribution to surface ectoderm
(arrowhead) and wild-type contribution to the mesenchyme. (G,I) Transverse
sections of branchial arches and head mesenchyme from chimeras generated by
injection of Pdgfra-/- ES cells into ROSA26+/-
blastocysts (CH11). (H,J) Transverse sections through similar regions to those
in G and I for chimeras made by injection of Pdgfra-/-;
ROSA26+/- ES cells into wild-type blastocysts (CH10). nt, neural
tube; se, surface ectoderm; lb, limb bud; ov, otic vesicle; ba1, branchial
arch 1; ba2, branchial arch 2; fb, forebrain. Arrows in G-J indicate regions
of mesoderm-derived muscle progenitors. Arrowheads in C indicate location of
occasional wild-type cells.
|